Reply to: Did antiphospholipid antibodies limit intervention efficacy for postoperative total knee arthroplasty-related thrombotic event prevention?

Clicks: 321
ID: 95637
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #10 of 23 articles by views in arthritis care & research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Dr. Rothschild provides important insights regarding the study of anticoagulation in persons with antiphospholipid syndrome (APS). The presence of any of several antiphospholipid antibodies can result in a hypercoagulable state leading to increased incidence of arterial and/or venous thromboses.
Reference Key
smith2020replyarthritis Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Smith, Savannah R;Katz, Jeffrey N;Losina, Elena;
Journal arthritis care & research
Year 2020
DOI
10.1002/acr.24161
URL
Keywords
corrigendum

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.